Nanobiotix
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-09-30 |
|---|---|---|---|
Revenue | $9,289 | $32,915 | $16,457 |
Gross Profit | 9,289 | 32,915 | 16,457 |
EBITDA | -23,244 | 1,413 | 706 |
EBIT | -23,531 | 1,139 | 569 |
Net Income | -21,872 | -11,601 | -5,800 |
Net Change In Cash | 9,289 | 32,915 | 16,457 |
Free Cash Flow | -6,325 | 4,794 | 2,397 |
Cash | 66,334 | 75,283 | 75,283 |
Basic Shares | 47,124 | 38,819 | 38,819 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $36,208 | $4,776 | $10 | $50 |
Gross Profit | 36,208 | 3,791 | 10 | 50 |
EBITDA | -23,686 | -45,151 | -45,605 | -31,494 |
EBIT | -24,237 | -46,651 | -47,165 | -33,249 |
Net Income | -39,700 | -57,043 | -47,004 | -33,623 |
Net Change In Cash | 36,208 | 4,776 | 10 | 50 |
Free Cash Flow | -12,813 | -37,197 | -30,105 | -27,645 |
Cash | 75,283 | 41,388 | 83,921 | 119,151 |
Basic Shares | 36,928 | 34,851 | 34,733 | 24,385 |
Earnings Calls
| Quarter | EPS |
|---|---|
2021-03-31 | -$0.52 |
2020-12-31 | -$0.51 |
